| Old Articles: <Older 45001-45010 Newer> |
|---|
 |
The Motley Fool
October 26, 2010
Esterhuizen & Sellitti |
9 REITs With Bearish Options Sentiment Following is a list of Real Estate Investment Trusts that options traders think will falter. Is there pessimism justified?   |
The Motley Fool
October 26, 2010
Brian Orelli |
Thank Goodness for Amgen's New Kids The old drugs are dragging down Amgen's growth. |
The Motley Fool
October 26, 2010
Travis Hoium |
ARIAD Pharmaceuticals Shares Plunged: What You Need to Know A day after shares pop, the company announced a stock offering at $3.70 per share, and shares drop. |
The Motley Fool
October 26, 2010
Tim Beyers |
Compellent Technologies Shares Soared: What You Need to Know Shares of Compellent Technologies rose more than 10% in intraday trading on no news whatsoever. Buyout speculation may have fueled the rally. |
The Motley Fool
October 26, 2010
Anand Chokkavelu |
5 Stocks That Are Sitting on a Market-Thrashing Opportunity To take advantage of share buybacks, a company needs plentiful cash. It also needs a cheap share price. These five have it. |
The Motley Fool
October 26, 2010
Anand Chokkavelu |
7 Transportation Stocks Near 52-Week Lows These are the top seven companies in this space (by market cap) that are hugging 52-week lows: Copa Holdings... Landstar System... Knight Transportation... Werner Enterprises... Heartland Express... Nordic American... Allegiant Travel... |
The Motley Fool
October 26, 2010
Esterhuizen & Sellitti |
7 Insider Executives Betting on a Housing Recovery Are investors overreacting to the housing market's woes? |
The Motley Fool
October 26, 2010
Brian Stoffel |
3 Reasons to Buy This Stock Despite delays, Nintendo's 3-D game system will impress. |
The Motley Fool
October 26, 2010
Seth Jayson |
Looking Into the Crystal Ball for LDK Solar Is LDK Solar sending any potential warning signs? Let's look at accounts receivable and days sales outstanding to find out. |
The Motley Fool
October 26, 2010
Seth Jayson |
From Gross to Net at Gilead Sciences Here's the margin picture for Gilead Sciences over the past few years. |
| <Older 45001-45010 Newer> Return to current articles. |
